Paediatric drug optimization for antibiotics

  19 April 2023

Paediatric drug optimization (PADO) exercises aim to identify key priority products and their preferred product characteristics for research and development. These have been successfully undertaken for HIV, hepatitis C and tuberculosis, demonstrating their potential and impact to accelerate access to optimal formulations in the context of fragmented, small markets for medicines for children.

To address the remaining research gaps that hinder availability of appropriate therapeutics for children with bacterial infections, WHO convened and facilitated a paediatric exercise for antibiotics to ensure that research and development efforts in this field target a priority list of medicines, ensuring that children with bacterial infections can also rapidly benefit from safe, effective and accessible treatment options

Further reading: WHO
Author(s): WHO
Healthy Patients   Kids and Carers  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed